Views & Analysis New research: can pharma get healthy rewards for good behavi... Research shows industry needs to see more evidence of success for wider adoption.
Views & Analysis Every voice matters: demand assessment in rare diseases A market research approach suitable for the complexities found in rare diseases.
Views & Analysis Incorporating ‘fast thinking’ into market research Accessing the ‘fast-thinking’ side of the brain through digital approaches can elicit better responses during market research.
Views & Analysis Harnessing video data to tell the real-world story Video offers researchers the opportunity to mine more data from subjects sharing powerful insights via mobile devices.
Views & Analysis Why doctors delay switching to new drugs In the first of two articles, Theano Anastasopoulou uses behavioural economics to understand and investigate how physicians make decisions and thereby improve the take-up of new medicines.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
